| scholarly article | Q13442814 |
| P50 | author | Babbette LaMarca | Q88459247 |
| Gerd Wallukat | Q63288594 | ||
| Ralf Dechend | Q63812628 | ||
| P2093 | author name string | Mark W Cunningham | |
| Jan M Williams | |||
| Lorena Amaral | |||
| Nathan Usry | |||
| P2860 | cites work | Preeclampsia: long-term consequences for vascular health | Q26800272 |
| Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond | Q27027039 | ||
| Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia | Q28083676 | ||
| What we have learned about preeclampsia | Q28196892 | ||
| Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia | Q68432345 | ||
| Does nitric oxide play a role in normal pregnancy and pregnancy-induced hypertension? | Q72578476 | ||
| Reduced sensitivity of the renal circulation to angiotensin II in pregnant rats | Q73762358 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Renin-angiotensin-aldosterone system in pregnancy-induced hypertension | Q73896725 | ||
| Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia | Q74527090 | ||
| Pre-eclampsia | Q81446389 | ||
| Changes in cardiac structure and function in rats immunized by angiotensin type 1 receptor peptides | Q82259476 | ||
| Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
| Angiotensin II type I receptor agonistic autoantibody-induced apoptosis in neonatal rat cardiomyocytes is dependent on the generation of tumor necrosis factor-α | Q95445011 | ||
| Renal redox response to normal pregnancy in the rat | Q28395942 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| The role of inflammation in the pathology of preeclampsia | Q33834419 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Maternal glomerular filtration rate in pregnancy and fetal size | Q33864460 | ||
| Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q34182166 | ||
| Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy | Q34453242 | ||
| A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
| AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia | Q35689550 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats | Q35994304 | ||
| Activating auto-antibodies against the AT1 receptor in preeclampsia | Q36010629 | ||
| Role of the renin-angiotensin system in the pathogenesis of preeclampsia | Q36064478 | ||
| IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy | Q36178540 | ||
| Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Sodium-renin-aldosterone relations in normal and hypertensive pregnancy | Q36429185 | ||
| Renal function during normal pregnancy and preeclampsia | Q36664126 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia | Q37042332 | ||
| Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension | Q37353499 | ||
| Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy | Q37353537 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor | Q38228306 | ||
| Oxidative stress in pregnancy and fertility pathologies | Q38230280 | ||
| Renal hemodynamics and tubular function normal human pregnancy | Q40295235 | ||
| A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism | Q41531265 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| Angiotensin II receptor type 1 autoantibodies promote endothelial microparticles formation through activating p38 MAPK pathway | Q46922047 | ||
| Inflammatory cytokines, vascular function, and hypertension | Q47606320 | ||
| Plasma volume and glomerular filtration rate in pregnancy and their relation to differences in fetal growth. | Q47938222 | ||
| Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. | Q54112770 | ||
| Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia | Q57254079 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 1308-1313 | |
| P577 | publication date | 2016-10-03 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy | |
| P478 | volume | 68 |
| Q53700889 | AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats. |
| Q64255839 | Cardiovascular System in Preeclampsia and Beyond |
| Q96230486 | Increased AT2R expression is induced by AT1R autoantibody via two axes, Klf-5/IRF-1 and circErbB4/miR-29a-5p, to promote VSMC migration |
| Q38707968 | Increased Angiotensin II Sensitivity Contributes to Microvascular Dysfunction in Women Who Have Had Preeclampsia |
| Q64115613 | Limited AT1 Receptor Internalization Is a Novel Mechanism Underlying Sustained Vasoconstriction Induced by AT1 Receptor Autoantibody From Preeclampsia |
| Q90434468 | Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia |
| Q57127734 | Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassay |
| Q92071252 | Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy |
| Q57167914 | Residual Vascular Dysfunction in Women with a History of Preeclampsia |
| Q91910507 | The angiotensin II type I receptor contributes to impaired cerebral blood flow autoregulation caused by placental ischemia in pregnant rats |
| Q57150158 | The role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia |
Search more.